Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GATTINONI, Luca")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 19 of 19

  • Page / 1
Export

Selection :

  • and

Wnt/β-Catenin Signaling in T-Cell Immunity and Cancer ImmunotherapyGATTINONI, Luca; YUN JI; RESTIFO, Nicholas P et al.Clinical cancer research (Print). 2010, Vol 16, Num 19, pp 4695-4701, issn 1078-0432, 7 p.Article

Sorting Through Subsets: Which T-Cell Populations Mediate Highly Effective Adoptive Immunotherapy?KLEBANOFF, Christopher A; GATTINONI, Luca; RESTIFO, Nicholas P et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 9, pp 651-660, issn 1524-9557, 10 p.Article

Case 2. Regionally advanced nasal cavity melanomaDEL VECCHIO, Michele; GATTINONI, Luca; LOZZA, Laura et al.Journal of clinical oncology. 2004, Vol 22, Num 4, pp 745-746, issn 0732-183X, 2 p.Article

CD8+ T-cell memory in tumor immunology and immunotherapyKLEBANOFF, Christopher A; GATTINONI, Luca; RESTIFO, Nicholas P et al.Immunological reviews. 2006, Vol 211, pp 214-224, issn 0105-2896, 11 p.Article

Determinants of Successful CD8+ T-Cell Adoptive Immunotherapy for Large Established Tumors in MiceKLEBANOFF, Christopher A; GATTINONI, Luca; ROSENBERG, Steven A et al.Clinical cancer research (Print). 2011, Vol 17, Num 16, pp 5343-5352, issn 1078-0432, 10 p.Article

CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependentGATTINONI, Luca; RANGANATHAN, Anju; SURMAN, Deborah R et al.Blood. 2006, Vol 108, Num 12, pp 3818-3823, issn 0006-4971, 6 p.Article

T-Cell Receptor Gene Therapy of Established Tumors in a Murine Melanoma ModelABAD, John D; WRZENSINSKI, Claudia; HAANEN, John B. A. G et al.Journal of immunotherapy (1997). 2008, Vol 31, Num 1, pp 1-6, issn 1524-9557, 6 p.Article

Increased Intensity Lymphodepletion Enhances Tumor Treatment Efficacy of Adoptively Transferred Tumor-specific T CellsWRZESINSKI, Claudia; PAULOS, Chrystal M; KAISER, Andrew et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 1, pp 1-7, issn 1524-9557, 7 p.Article

Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via notch signalingYANGBING ZHAO; PARKHURST, Maria R; ZHILI ZHENG et al.Cancer research (Baltimore). 2007, Vol 67, Num 6, pp 2425-2429, issn 0008-5472, 5 p.Article

Genetic Engineering of Murine CD8+ and CD4+ T Cells for Preclinical Adoptive Immunotherapy StudiesKERKAR, Sid P; SANCHEZ-PEREZ, Luis; SCOTT, Christopher D et al.Journal of immunotherapy (1997). 2011, Vol 34, Num 4, pp 343-352, issn 1524-9557, 10 p.Article

Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted HostsKERKAR, Sid P; MURANSKI, Pawel; MORGAN, Richard A et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 17, pp 6725-6734, issn 0008-5472, 10 p.Article

Could exemestane affect insulin-like growth factors, interleukin 6 and bone metabolism in postmenopausal advanced breast cancer patients after failure on aminoglutethimide, anastrozole or letrozole?FERRARI, Leonardo; BAJETTA, Emilio; MARTINETTI, Antonia et al.International journal of oncology. 2003, Vol 22, Num 5, pp 1081-1089, issn 1019-6439, 9 p.Article

IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. CommentaryDARCY, Phillip K; HINRICHS, Christian S; RESTIFO, Nicholas P et al.Blood. 2008, Vol 111, Num 11, issn 0006-4971, 5268-5269, 5326-5333 [10 p.]Article

Tumor-specific Th17-polarized cells eradicate large established melanoma. CommentaryBRONTE, Vincenzo; MURANSKI, Pawel; PTAK, Krzysztof et al.Blood. 2008, Vol 112, Num 2, issn 0006-4971, 214, 362-373 [13 p.]Article

Prognostic significance of cancer-testis gene expression in resected non-small cell lung cancer patientsMELLONI, Giulio; FERRERI, Andres J. M; RUSSO, Vincenzo et al.Oncology reports. 2004, Vol 12, Num 1, pp 145-151, issn 1021-335X, 7 p.Article

Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapyHINRICHS, Christian S; BORMAN, Zachary A; MURANSKI, Pawel et al.Blood. 2011, Vol 117, Num 3, pp 808-814, issn 0006-4971, 7 p.Article

Programming tumor-reactive effector memory CD8+ T cells in vitro obviates the requirement for in vivo vaccinationKLEBANOFF, ChristopherA; ZHIYA YU; HWANG, Leroy N et al.Blood. 2009, Vol 114, Num 9, pp 1776-1783, issn 0006-4971, 8 p.Article

Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriersBONI, Andrea; MURANSKI, Pawel; RESTIFO, Nicholas P et al.Blood. 2008, Vol 112, Num 12, pp 4746-4754, issn 0006-4971, 9 p.Article

Toll-like receptors in tumor immunotherapyPAULOS, Chrystal M; KAISER, Andrew; ANTONY, Paul A et al.Clinical cancer research. 2007, Vol 13, Num 18, pp 5280-5289, issn 1078-0432, 10 p., 1Article

  • Page / 1